Smokers more likely to experience vision loss

News
Article

Research indicates smoking increases risk of AMD, cataracts and glaucoma

A no smoking sign hanging on a wall. ©stock.adobe.com – generated with Firefly AI

National No Smoking Day is on Wednesday 13 March in the UK. ©stock.adobe.com – generated with Firefly AI

The risks associated with smoking are not limited to increased risks of cancer and heart disease. Smoking also can be detrimental to vision. In fact, smokers are more likely to experience visual loss, according to a press release issued by Moorfields Eye Hospital, London, in anticipation of National No Smoking Day on Wednesday 13 March in the UK.

Consultant ophthalmologist Mr Luke Nicholson, who leads the medical retina services at Moorfields Eye Hospital, flags the increased associated risks with age-related macular degeneration (AMD).

Eye care providers at Moorfields state that more public awareness is needed regarding the risks associated with smoking and sight loss, because less is known about the effects of smoking on ocular health.

According to Mr Nicholson, “In my role, I have seen the negative impact that smoking has on patients. Quitting smoking brings clear benefits to our health but also protects our retina from developing some irreversible diseases and safeguards our vision.”

Research shows that smoking has been associated with increasing the risk of developing AMD, cataracts and glaucoma.

AMD is the most common cause of sight loss in the UK. If patients already have some form of AMD, research indicates that smoking may also be associated with progression to more advanced forms of the disease.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.